Wells Fargo’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
1,274,390
+354,911
+39% +$452K ﹤0.01% 3505
2025
Q4
$1M Buy
919,479
+205,166
+29% +$229K ﹤0.01% 3970
2025
Q3
$721K Buy
714,313
+487,453
+215% +$532K ﹤0.01% 4043
2025
Q2
$261K Buy
226,860
+224,710
+10,452% +$290K ﹤0.01% 4611
2025
Q1
$3.2K Sell
2,150
-150
-7% -$180 ﹤0.01% 6095
2024
Q4
$1.88K Sell
2,300
-163
-7% -$144 ﹤0.01% 6196
2024
Q3
$2.01K Sell
2,463
-1,000
-29% -$819 ﹤0.01% 6055
2024
Q2
$2.84K Sell
3,463
-11,042
-76% -$9.36K ﹤0.01% 5963
2024
Q1
$11.7K Buy
14,505
+5,424
+60% +$7.04K ﹤0.01% 5713
2023
Q4
$12.8K Buy
9,081
+4
+0% +$5 ﹤0.01% 5764
2023
Q3
$10.6K Buy
9,077
+8,983
+9,556% +$13K ﹤0.01% 5795
2023
Q2
$131 Buy
94
+35
+59% +$53 ﹤0.01% 6813
2023
Q1
$83 Buy
59
+1
+2% +$1 ﹤0.01% 6975
2022
Q4
$79 Buy
58
+2
+4% +$4 ﹤0.01% 6856
2022
Q3
$0 Buy
56
+20
+56% +$50 ﹤0.01% 7072
2022
Q2
$0 Sell
36
-1,063
-97% -$2.36K ﹤0.01% 7205
2022
Q1
$4K Sell
1,099
-2,009
-65% -$7.34K ﹤0.01% 6529
2021
Q4
$16K Buy
+3,108
New +$25.2K ﹤0.01% 6399

Other funds holding LUCD

Wells Fargo's LUCD Position: Q1 2026 in Review

Wells Fargo increased its Lucid Diagnostics (LUCD) stake by 39% in Q1 2026, buying an estimated $452K and bringing the position to 1,274,390 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3505.

Wells Fargo first reported a position in LUCD in Q4 2021 and has held it in 18 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Wells Fargo held 1,274,390 shares of Lucid Diagnostics worth $1.47M as of Q1 2026.
  • Wells Fargo bought 354,911 Lucid Diagnostics shares in Q1 2026, an estimated $452K.
  • Lucid Diagnostics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3505 holding.
  • Wells Fargo first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 18 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.